Impact of the selective serotonin reuptake inhibitor citalopram on insulin sensitivity, leptin and basal cortisol secretion in depressed and non-depressed euglycemic women of reproductive age

References

• Goodnick P J, Henry J H, Buki U M. Treatment of depression in patients with diabetes mellitus. J Clin Psychiatry 1995; 56: 128–136
   PubMed Web of Science ®Google Scholar
• Lapane K L, Zierler S, Lasater T M, Stein M, Barbour M M, Hume A L. Is a history of depressive symptoms associated with an increased incidence of infertility in women?. Psychosom Med 1995; 57: 509–513
   PubMed Web of Science ®Google Scholar
• Linkowski P, Mendlewicz J, Leclercq R. The 24-hour profile of adrenocorticotropin and cortisol in major depressive illness. J Clin Endocrinol Metab 1985; 61: 429–438
   PubMed Web of Science ®Google Scholar
• Arato M, Banki C M, Nemeroff C B, Bissette G. Hypothalamic–pituitary–adrenal axis and suicide. Ann N Y Acad Sci 1986; 487: 263–270
   PubMedGoogle Scholar
• Banki C M, Karmacsi L, Bissette G, Nemeroff C B. CSF corticotropin-releasing and somatostatin in major depression: response to antidepressant treatment and relapse. Eur Neuropsychopharmacol 1992; 2: 107–113
   PubMedGoogle Scholar
• Deuschle M, Hamann B, Meichel C, Krumm B, Lederbogen F, Kniest A, Colla M, Heuser I. Antidepressant treatment with amitriptyline and paroxetine: effects on saliva cortisol concentrations. J Clin Psychopharmacol 2003; 23: 201–215
   Google Scholar
• Holsboer F, Barden N. Antidepressants and hypothalamic–pituitary–adrenocortical regulation. Endocr Rev 1996; 17: 187–205
   PubMed Web of Science ®Google Scholar
• Winokur A, Maislin G, Phillips J L, Amsterdam J D. Insulin resistance after oral glucose tolerance testing in patients with major depression. Am J Psychiatry 1988; 145: 325–330
   PubMed Web of Science ®Google Scholar
• Mueller P S, Heminger G R, McDonald R K. Intravenous glucose tolerance test in depression. Arch Gen Psychiatry 1969; 21: 470–477
   PubMed Web of Science ®Google Scholar
• Wright J H, Jacisin J J, Radin N S. Glucose metabolism in unipolar depression. Br J Psychiatry 1978; 132: 386–393
   PubMed Web of Science ®Google Scholar
• Herzberg B, Coppen A, Marks V. Glucose tolerance in depression. Br J Psychiatry 1968; 14: 421–427
   Google Scholar
• Heninger G R, Mueller P S, Daws L S. Depressive symptoms and the glucose tolerance test and insulin tolerance test. J Nerv Ment Dis 1975; 161: 471–477
   Google Scholar
• Okamura F, Tashiro A, Utumi A, Imai T, Suchi T, Tamura D, Sato Y, Suzuki S, Hongo M. Insulin resistance in patients with depression and its changes during the clinical course of depression: minimal model analysis. Metabolism 2000; 49: 1255–1260
   PubMed Web of Science ®Google Scholar
• Nathan R S, Sachcer E J, Asnis G M, Halbreich U, Halpern F s. Relative insulin insensitivity and cortisol in depressed patients. Psychiatry Res 1981; 4: 291–300
   PubMedGoogle Scholar
• Goodnick P J. Use of antidepressants in treatment of comorbid diabetes mellitus and depression as well as in diabetic nephropathy. Ann Clin Psychiatry 2001; 13: 31–41
   PubMedGoogle Scholar
• Laakmann G, Hinz A, Voderholzer U, Daffner C, Muller O A, Neuhauser H, Neulinger E, Wittmann M. The influence of psychotropic drugs and releasing hormones on anterior pituitary hormone secretion in health subjects and depressed patients. Pharmacopsychiatry 1990; 23: 18–26
   Google Scholar
• Wyatt R J, Portnoy B, Kupfer D J, Snyder F, Engelman K. Resting plasma catecholamine concentrations in patients with depression and anxiety. Arch Gen Psychiatry 1971; 24: 65–70
   PubMed Web of Science ®Google Scholar
• Veith R C, Lewis N, Linares O A, Barnes R F, Raskind M A, Villacres E C, Murburg M M, Ashleigh E A, Castillo S, Peskind E R, et al. Sympathetic nervous system activity in major depression. Basal and desipramine-induced alterations in plasma norepinephrine kinetics. Arch Gen Psychiatry 1994; 51: 411–422
   Google Scholar
• Owens M J, Nemeroff C B. Role of serotonin in the pathophysiology of depression: focus on the serotonin transporter. Clin Chem 1994; 40: 288–295
   PubMed Web of Science ®Google Scholar
• Kopf D, Westphal S, Luley C W, Ritter S, Gilles M, Weber-Hamann B, Lederbogen F, Lehnert H, Henn F A, Heuser I, et al. Lipid metabolism and insulin resistance in depressed patients: significance of weight, hypercortisolism, and antidepressant treatment. J Clin Psychopharmacol 2004; 24: 527–531
   Google Scholar
• Fava M, Judge R, Hoog S L, Nilsson M E, Koke S C. Fluoxetine versus sertraline and paroxetine in major depressed disorders: changes in weight gain with long-term treatment. J Clin Psychiatry 2000; 61: 863–867
   PubMed Web of Science ®Google Scholar
• Weissenburger J, Rush A, Giles D, Stunkard A J. Weight change in depression. Psychiatry Res 1986; 17: 275–283
   PubMed Web of Science ®Google Scholar
• Carmina E, Ferin M, Gonzales F, Lobo R A. Evidence that insulin and androgens may participate in the regulation of serum leptin levels in women. Fertil Steril 1999; 72: 926–931
   PubMed Web of Science ®Google Scholar
• Henson M C, Castracane V D. Leptin and Reproduction. Kluwer Academic/Plenum Publishers, New York 2003
   Google Scholar
• Kraus T, Haack M, Schuld A, Hinze-Selch D, Pollmacher T. Low leptin levels but normal body mass indices in patients with depression or schizophrenia. Neuroendocrinology 2001; 73: 243–247
   PubMed Web of Science ®Google Scholar
• Atmaca M, Kuloglu M, Tezcan E, Ustundag B, Gecici O, Firidin B. Serum leptin and cholesterol values in suicide attemptors. Neuropsychobiology 2002; 45: 124–127
   PubMed Web of Science ®Google Scholar
• Hinze-Selch D, Schuld A, Kraus T, Kuhn M, Uhr M, Haack M, Pollmacher T. Effects of antidepressants on the plasma levels of leptin, TNF-α, and soluble TNF receptors: a longitudinal study in patients treated with amitriptypline or paroxetine. Neuropsychopharmacology 2000; 23: 13–19
   PubMed Web of Science ®Google Scholar
• Deuschle M, Blum W, Englaro P, Schweiger U, Weber B, Pflaum C D, Heuser I. Plasma leptin in depressed patients and healthy controls. Horm Metab Res 1996; 28: 714–717
   PubMed Web of Science ®Google Scholar
• Antonijevic I A, Murck H, Frieboes R M, Horn R, Brabant G, Steiger A. Elevated nocturnal profiles of serum leptin in patients with depression. J Psychiatr Res 1998; 32: 403–410
   PubMed Web of Science ®Google Scholar
• Maheux P, Dricous F, Bourque J. Fluoxetine improves insulin sensitivity in obese patients with non-insulin-dependent diabetes independent of weight loss. Int J Obes Relat Metab Disord 1997; 21: 97–102
   PubMed Web of Science ®Google Scholar
• France R D, Urban B, Krishran K R. CSF corticotrophin releasing factor-like immunoreactivity in chronic pain patients with or without major depression. Biol Psychiatry 1998; 23: 86–88
   Google Scholar
• Musselman D L, Nemeroff C B. Depression and endocrine disorders: focus on the thyroid and adrenal systems. Br J Psychiatry 1996; 30(Suppl)123–128
   Google Scholar
• Calabrese J R, Londborg M D, Shelton M D, Thase M E. Citalopram treatment of fluoxetine-intolerant depressed patients. J Clin Psychiatry 2003; 64: 562–567
   Google Scholar
• Hyttel J. Pharmacologic characterization of selective serotonin reuptake inhibitors (SSRIs). Int Clin Psychopharmacol 1994; 9(Suppl 1)19–26
   PubMedGoogle Scholar
• Kuehner C. Gender differences in unipolar depression: an update of epidemiological findings and possible explanations. Acta Psychiatr Scand 2003; 108: 163–174
   PubMed Web of Science ®Google Scholar
• Beck A, Ward C, Mendelson M. An inventory for measuring depression. Arch Gen Psychiatry 1961; 4: 561–571
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1999; 22(Suppl 1)S5–S19
   Google Scholar
• Tucker P, Beebe K, Burgin C, Wyatt D B, Parker D E, Masters B K, Nawar O. Paroxetine treatment of depression with posttraumatic stress disorder: effects on autonomic reactivity and cortisol secretion. J Clin Psychopharmacol 2004; 24: 131–140
   Google Scholar
• Kraus T, Haack M, Schuld A, Hinze-Selch D, Koethe D, Pollmacher T. Body weight, the tumor necrosis factor system, and leptin production during treatment with mirtazepine or venlafaxine. Pharmacopsychiatry 2002; 35: 220–225
   PubMed Web of Science ®Google Scholar
• Timonen M, Laakso M, Jokelainen J, Rajala U, Meyer-Rochow V B, Keinanen-Kiukaanniemi S. Insulin resistance and depression: cross sectional study. BMJ 2005; 330: 17–18
   PubMedGoogle Scholar
• Lawlor D A, Smith D S, Ebrahim S. Association of insulin resistance with depression: cross sectional findings from the British women's heart and health study. BMJ 2003; 327: 1383–1384
   Google Scholar
• Golomb B A, Tenkanen L, Alikoski T, Niskanen T, Manninen V, Huttunen M, Mednick S A. Insulin sensitivity markers: predictors of accidents and suicides in the Helsinki Heart Study screenees. J Clin Epidemiol 2002; 55: 767–773
   PubMed Web of Science ®Google Scholar
• Okamura F, Tashiro A, Utsumi A, Imai T, Suchi T, Hongo M. Insulin resistance in patients with depression and its changes in the clinical course of depression: a report of three cases using the minimal model analysis. Intern Med 1999; 38: 257–260
   Google Scholar
• Potter van Loon B J, Radder J K, Frolich M. Fluoxetine increases insulin action in obese type II diabetic patients. Int J Obes Relat Metab Disord 1992; 16(Suppl 4)551–556
   Google Scholar
• Legro R S, Castracane V D, Kauffman R P. Measurement of insulin resistance in polycystic ovary disease: promises and pitfalls. Obstet Gynecol Surv 2004; 59: 144–154
   Google Scholar